Additionally, insulin therapy for a long time is unsatisfactorily associated with some disadvantages, such as insulin resistance, weight gain, dyslipidemia, and hypoglycemia (6, 7), that are of deep concern in T1DM because they could influence therapy compliance and result in an increased mortality rate (8, 9). The gene discussed is INS; the disease is Hypoglycemia.